What are the responsibilities and job description for the Preclinical Forum position at Physician Renaissance Network?
Posted on August 11, 2011 by PRN | Leave a comment
CBI will hold a Pharma/Bio Forum on Preclinical Development titled “Utilize Biomarkers and Leverage Partnerships for Earlier Toxicity Detection.” The conference will take place on September 26-27 at the Hyatt Harborside in Boston, MA.
This Scientific 2-day Conference Will Cover
Translational capabilities for accelerated research
Innovative metabolic and oncologic therapeutics
Beneficial partnerships with academia and CROs
Biomarker assessment and preclinical toxicity considerations
Over the past several years, drug discovery and preclinical R&D have been severely affected by the recession cuts. Going forward, the industry looks to strategically utilize available resources for their preclinical development in a cost-effective and timely manner. This conference assesses available opportunities for bio/pharmaceutical companies to accelerate research, utilize R&D technology and leverage partnerships throughout development. Specific considerations include: biomarkers, translational research, orphan drugs and global development.
10 Key Bene Fit s Of Attending
« Allscripts Content Editors
Managing Risk »
Leave a Reply Cancel reply
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Δ
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Do You Feel Like You Wasted All That Training?
Questions from Doctors Considering a Career Change
CBI will hold a Pharma/Bio Forum on Preclinical Development titled “Utilize Biomarkers and Leverage Partnerships for Earlier Toxicity Detection.” The conference will take place on September 26-27 at the Hyatt Harborside in Boston, MA.
This Scientific 2-day Conference Will Cover
Translational capabilities for accelerated research
Innovative metabolic and oncologic therapeutics
Beneficial partnerships with academia and CROs
Biomarker assessment and preclinical toxicity considerations
Over the past several years, drug discovery and preclinical R&D have been severely affected by the recession cuts. Going forward, the industry looks to strategically utilize available resources for their preclinical development in a cost-effective and timely manner. This conference assesses available opportunities for bio/pharmaceutical companies to accelerate research, utilize R&D technology and leverage partnerships throughout development. Specific considerations include: biomarkers, translational research, orphan drugs and global development.
10 Key Bene Fit s Of Attending
- Steps you can take to strengthen your IND submissions
- Learn what both sides of in-licensing and out-licensing need to know
- Understand how Merrimack Pharmaceuticals is using human stem cell-derived cardiomyocytes
- Examine preclinical considerations in the discovery of novel oncology therapeutics
- Leverage partnerships with academic institutions
- Use efficacy and safety biomarkers in preclinical studies
- Develop regulatory and safety strategies for novel constructs
- Explore how VIA Pharmaceuticals is developing a novel thyroid hormone agonist
- Structure an exploratory strategy at lead optimization
- Identify drivers for recent growth of orphan drug development at Pfizer
« Allscripts Content Editors
Managing Risk »
Leave a Reply Cancel reply
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Δ
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Do You Feel Like You Wasted All That Training?
Questions from Doctors Considering a Career Change
- Tweets by PRNresource
- Opportunities for Physicians with Engineering Degrees Job opportunities at BRC: ANALYZING HOW INJURIES ARE CAUSED Do ...
- Kóan Jeff Baysa, MD Kóan Jeff Baysa, a member of PRN, is an independent contemporary ...
- Non-Clinical Careers Conference SEAK will be holding their 10th Annual Non-Clinical Careers for ...
- Pharma Industry Jobs for Physicians Look for Zebras founder Sylvie Stacy, MD, MPH, has written ...
- Popular Topics Popular Topics Select Category Biotech and Devices Career Change Communications Companies Courses/Certification Creative Arts Education Center Events FMSG Hospital Administration Informatics Insurance Investment/VC JD Jobs Legal MBA Medical Associations MPH News Non-Clinical Career News Non-Clinical Careers Non-Clinical Profiles Other Pharmaceuticals Physician Consulting Physician Entrepreneurism Physician Networking Physician Volunteer Physicians PRN News Public Health Publishing Research Uncategorized